Federal Trade Commission v. A.S. Research, LLC
This text of Federal Trade Commission v. A.S. Research, LLC (Federal Trade Commission v. A.S. Research, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Chief Judge Philip A. Brimmer Civil Action No. 19-cv-03423-PAB-KMT FEDERAL TRADE COMMISSION, Plaintiff, v. A.S. RESEARCH, LLC, also d/b/a ASR and APPLIED SCIENTIFIC RESEARCH LABS, a limited liability company, STEPHEN J. YOUNG, individually and as an owner and officer of A.S. RESEARCH, LLC, and MICHAEL K. LEDEBOER, individually and as an owner and officer of A.S. RESEARCH, LLC, Defendants. _____________________________________________________________________ ORDER _____________________________________________________________________ This matter is before the Court on the Motion to Withdraw Consent and Opposition to Application in Light of COVID-19 [Docket No. 8]. Defendants seek to withdraw their consent to the Stipulated Agreement [Docket No. 2-1] for a permanent injunction and other equitable relief. Docket No. 8 at 7. Plaintiff responded in opposition to defendants’ motion to withdraw consent on May 6, 2020, Docket No. 14, and defendants replied on May 15, 2020. Docket No. 17. On December 5, 2019 plaintiff filed a Complaint for Permanent Injunction and Other Equitable Relief [Docket No. 1] alleging that defendants engaged in unfair or deceptive acts in violation of the FTC Act, 15 U.S.C. § 45(a), in the course of marketing and promoting the drug Synovia. Docket No. 1 at 16, ¶¶ 17-19. Specifically, plaintiff alleges that defendants made false or misleading representations concerning the drug’s effectiveness, fabricated customer testimonials, and made misrepresentations concerning expert endorsements of the drug. See, e.g., id. at 17-22, ¶¶ 21-22, 27, 30- 31, 36-37. Along with its complaint, plaintiff filed an Unopposed Motion for Entry of Proposed Stipulated Order for Permanent Injunction and Monetary Judgment. Docket
No. 2. Plaintiff represents that, “[p]rior to the complaint filing, the FTC and Defendants agreed to the attached proposed Stipulated Order for Permanent Injunction and Monetary Judgment . . . which resolves all matters in dispute in action between them.” Id. at 1. Despite the parties’ Stipulated Agreement for a permanent injunction, Docket No. 2-1, defendants now indicate that they no longer agree to the terms to which they previously assented. See Docket No. 8. Defendants state that “COVID-19 has
resulted in the parties’ objectives being impossible to meet and the obligations of [defendants] under the [Stipulated Agreement] impossible to perform in a timely fashion, or to perform at all, compared to the parties’ expectations at the time” the parties entered into their settlement agreement. Id. at 4, ¶ 24. Defendants request that the Court “refrain from signing off and ordering the [Stipulated Agreement] proffered by the FTC with the prior consent of the Defendants and direct the parties to collaboratively re-address the monetary sanctions imposed therein, or to otherwise have the Court issue the [Stipulated Agreement] with amended financial sanctions
imposed in an amount this Court deems just and appropriate given the circumstances involved.” Docket No. 8 at 7.1 Plaintiff opposes this request, arguing that defendants’ 1 To the extent that defendants request that the Court modify the parties’ private contractual agreement, it cannot do so. Janicek v. Obsideo, LLC, 271 P.3d 1133, 1138 motion contravenes the parties’ agreement and that plaintiff will be deprived of the benefit of its bargain in entering the agreement should the agreement not be enforced as written. Docket No. 14 at 2. “Generally, a ‘trial court has the power to summarily enforce a settlement
agreement entered into by the litigants while litigation is pending before it.’” Mitchell v. Estrada, No. 03-cv-00387-PAB-MJW, 2013 WL 4502268, at *2 (D. Colo. Aug. 23, 2013) (quoting United States v. Hardage, 982 F.2d 1491, 1496 (10th Cir. 1993)); DiFrancesco v. Particle Interconnect Corp., 39 P.3d 1243, 1247 (Colo. App. 2001) (“A court may summarily enforce a settlement agreement if it is undisputed that a settlement exists”).2 “Issues involving the formation and construction of a purported settlement agreement
are resolved by applying state contract law.” Shoels v. Klebold, 375 F.3d 1054, 1060 (10th Cir. 2004). Defendants do not dispute that they entered into the Stipulated Agreement and assented to the terms therein. Docket No. 17 at 1. Thus, the Court has authority to enforce the parties’ settlement agreement while litigation is pending. DiFrancesco, 39 P.3d at 1247. While defendants appear to raise an impossibility-of-performance argument in their motion, see Docket No. 8 at 4, ¶ 24, they assert in their reply that their motion is not based on an impossibility-of-performance argument. Docket No. 17 at 1-2. In fact,
(Colo. App. 2011). 2 Both parties assume that Colorado contract law applies. See Docket No. 14 at 8; Docket No. 17 at 1-2. Accordingly, the Court makes this same assumption and will apply Colorado law. defendants concede that “it is possible for Defendants to pay” the amount specified in the Stipulated Agreement, i.e., it is possible for them to carry out the contractual terms, as “the money [to be paid] is sitting in [defendants’] lawyer’s trust account.” Id. at 2. Instead, defendants assert that they can avoid enforcement of the Stipulated
Agreement using a frustration-of-purpose defense. Id. “The party seeking to avoid the obligations in the contract . . . on grounds of frustration of purpose must show total, or near total, destruction of the essential purpose of the transaction.” Beals v. Tri-B Assocs., 644 P.2d 78, 80-81 (Colo. App. 1982). Although defendants state that “COVID-19 has resulted in the parties’ objectives being impossible to meet,” see Docket No. 8 at 4, ¶ 24, the Court finds that this is insufficient to constitute a frustration-of-purpose argument. Defendants make no
attempt in their motion to identify the intended purpose of the Stipulated Agreement, and do not argue that this specific purpose was frustrated. See generally id. In fact, defendants do not use the terms “purpose,” “frustrate,” or “frustration of purpose” at any point in their motion. See id. “Undeveloped arguments raised in a perfunctory manner are waived.” Schlecht v. Lockheed Martin Corp., 11-cv-03072-RM-BNB, 2014 WL 6778709, at *2 (D. Colo. Nov. 25, 2014), aff’d, 626 Fed. Appx. 775 (10th Cir. 2015).3 Changed economic circumstances also provide no basis for changing the parties’ bargain. “The risk that economic conditions may change . . . [is] not so
unforeseeable that [it is] outside the risks assumed under the contract.” Beals, 644
3 While defendants shift to a more explicit frustration-of-purpose argument in their reply, see Docket No. 17 at 2, “a party waives issues and arguments raised for the first time in a reply brief.” Gutierrez v. Cobos, 841 F.3d 895, 902 (10th Cir. 2016). P.2d at 81; see also Restatement (Second) of Contracts § 265 (1981) (“It is not enough that the transaction has become less profitable for the affected party or even that he will sustain a loss.”). In addition, defendants have not demonstrated that keeping A.S. Research in business was plaintiff’s “sole . . . [or] predominate” purpose in entering into
the agreement.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Federal Trade Commission v. A.S. Research, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/federal-trade-commission-v-as-research-llc-cod-2020.